首页> 外文期刊>Therapeutic innovation & regulatory science. >Studies of Product Structure Adjustment Routes for China's Pharmaceutical Industry: A View From the New Healthcare Reform Targets
【24h】

Studies of Product Structure Adjustment Routes for China's Pharmaceutical Industry: A View From the New Healthcare Reform Targets

机译:中国医药行业产品结构调整路径研究:新医疗改革目标的视角

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The 12th Five-Year Plan period is a critical period for the development of the pharmaceutical industry in China. A major focus coming with the New Healthcare Reform is a product structure adjustment in the pharmaceutical industry. Many researchers have been attracted in recent years to product structure adjustment studies.
机译:背景:“十二五”时期是中国医药工业发展的关键时期。新医疗改革带来的主要焦点是制药行业的产品结构调整。近年来,许多研究人员吸引了产品结构调整研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号